Cargando…
Non-sleepy obstructive sleep apnoea: to treat or not to treat?
Non-sleepy obstructive sleep apnoea (OSA) is thought to have a prevalence of around 20–25% in industrialised countries. However, the question of whether it should be routinely treated or not is controversial. This review collates the results from recent randomised controlled trials addressing OSA an...
Autores principales: | Altintas, Nejat, Riha, Renata L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488974/ https://www.ncbi.nlm.nih.gov/pubmed/31871125 http://dx.doi.org/10.1183/16000617.0031-2019 |
Ejemplares similares
-
Sex differences in obstructive sleep apnoea
por: Bonsignore, Maria R., et al.
Publicado: (2019) -
Obstructive sleep apnoea in acute coronary syndrome
por: Randerath, Winfried, et al.
Publicado: (2019) -
Self-reported sleepiness and not the apnoea hypopnoea index is the best predictor of sleepiness-related accidents in obstructive sleep apnoea
por: Philip, P., et al.
Publicado: (2020) -
Oxygen for the treatment of obstructive sleep apnoea hypopnoea syndrome
por: Riha, Renata L.
Publicado: (2019) -
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
por: Craig, Sonya, et al.
Publicado: (2022)